Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3302999310;99311;99312 chr2:178538744;178538743;178538742chr2:179403471;179403470;179403469
N2AB3138894387;94388;94389 chr2:178538744;178538743;178538742chr2:179403471;179403470;179403469
N2A3046191606;91607;91608 chr2:178538744;178538743;178538742chr2:179403471;179403470;179403469
N2B2396472115;72116;72117 chr2:178538744;178538743;178538742chr2:179403471;179403470;179403469
Novex-12408972490;72491;72492 chr2:178538744;178538743;178538742chr2:179403471;179403470;179403469
Novex-22415672691;72692;72693 chr2:178538744;178538743;178538742chr2:179403471;179403470;179403469
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Fn3-129
  • Domain position: 32
  • Structural Position: 34
  • Q(SASA): 0.5328
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/K rs1431873084 0.142 0.645 N 0.526 0.304 0.230578612272 gnomAD-2.1.1 4.02E-06 None None None None N None 0 2.9E-05 None 0 0 None 0 None 0 0 0
E/K rs1431873084 0.142 0.645 N 0.526 0.304 0.230578612272 gnomAD-4.0.0 1.59141E-06 None None None None N None 0 2.28645E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.1371 likely_benign 0.1512 benign -0.393 Destabilizing 0.645 D 0.569 neutral N 0.455702334 None None N
E/C 0.7731 likely_pathogenic 0.8027 pathogenic -0.249 Destabilizing 0.995 D 0.699 prob.neutral None None None None N
E/D 0.0663 likely_benign 0.0727 benign -0.398 Destabilizing 0.002 N 0.162 neutral N 0.483464938 None None N
E/F 0.7784 likely_pathogenic 0.8103 pathogenic -0.099 Destabilizing 0.995 D 0.661 neutral None None None None N
E/G 0.1554 likely_benign 0.1704 benign -0.626 Destabilizing 0.645 D 0.535 neutral N 0.487545393 None None N
E/H 0.4967 ambiguous 0.519 ambiguous 0.134 Stabilizing 0.985 D 0.591 neutral None None None None N
E/I 0.393 ambiguous 0.4304 ambiguous 0.197 Stabilizing 0.945 D 0.684 prob.neutral None None None None N
E/K 0.2147 likely_benign 0.209 benign 0.099 Stabilizing 0.645 D 0.526 neutral N 0.444138546 None None N
E/L 0.4061 ambiguous 0.4532 ambiguous 0.197 Stabilizing 0.945 D 0.679 prob.neutral None None None None N
E/M 0.4741 ambiguous 0.5232 ambiguous 0.187 Stabilizing 0.995 D 0.633 neutral None None None None N
E/N 0.1604 likely_benign 0.1742 benign -0.265 Destabilizing 0.809 D 0.555 neutral None None None None N
E/P 0.2493 likely_benign 0.2824 benign 0.021 Stabilizing 0.945 D 0.619 neutral None None None None N
E/Q 0.1773 likely_benign 0.1861 benign -0.198 Destabilizing 0.864 D 0.541 neutral N 0.498703749 None None N
E/R 0.3348 likely_benign 0.3368 benign 0.41 Stabilizing 0.894 D 0.617 neutral None None None None N
E/S 0.1679 likely_benign 0.1856 benign -0.452 Destabilizing 0.547 D 0.527 neutral None None None None N
E/T 0.2076 likely_benign 0.2328 benign -0.262 Destabilizing 0.894 D 0.557 neutral None None None None N
E/V 0.2228 likely_benign 0.2433 benign 0.021 Stabilizing 0.928 D 0.643 neutral N 0.50776595 None None N
E/W 0.8971 likely_pathogenic 0.9147 pathogenic 0.084 Stabilizing 0.995 D 0.705 prob.neutral None None None None N
E/Y 0.5849 likely_pathogenic 0.6188 pathogenic 0.143 Stabilizing 0.995 D 0.639 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.